GLP-1 combination therapy shows increased immune activity for psoriasis treatment
The Hill · October 12, 2026Original source ↗
What happened
A study indicated that a combination of GLP-1 medications results in increased inflammatory immune activity compared to the medication Taltz alone. This suggests a potential new approach for treating psoriasis patients.
Why it matters
This development could provide new treatment options for individuals with psoriasis.
How this story affects people
How does this story affect you if you have psoriasis?
This new research could provide you with additional treatment options, potentially leading to improved management of your condition. The increased immune activity observed with the combination therapy may offer a different approach to addressing your symptoms.
Read a briefing based on your profile
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Download on the App Store3 free Ripples in total. Read without an account. iPhone · iOS 26.0+ · United States
More stories
- HealthCDC reports third measles death but withholds state information
- HealthPennsylvania reports increase in congenital measles cases
- HealthPope Leo XIV does not require further treatment for lung cancer, according to doctors
- HealthFamilies of care home residents share experiences during Covid-19 restrictions